Veradermics, Incorporated (MANE)

NYSE: MANE · Real-Time Price · USD

50.27

+2.89 (6.10%)

Feb 18, 2026, 12:50 PM EST - Market open

Veradermics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Selling, General & Admin	6.48	3.5	2.35
Research & Development	48.82	23.28	14.97
Operating Expenses	55.31	26.78	17.32
Operating Income	-55.31	-26.78	-17.32
Interest Expense	-0.29	-0.59	-0.04
Interest & Investment Income	0.87	0.48	0.87
Other Non Operating Income (Expenses)	0.93	0.39	-
Pretax Income	-53.81	-26.49	-16.49
Net Income	-53.81	-26.49	-16.49
Preferred Dividends & Other Adjustments	7.83	0.82	-
Net Income to Common	-61.64	-27.3	-16.49
Shares Outstanding (Basic)	1	1	1
Shares Outstanding (Diluted)	1	1	1
EPS (Basic)	-83.10	-37.05	-22.38
EPS (Diluted)	-83.10	-37.05	-22.38
EBIT	-55.31	-26.78	-17.32

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q